Luis Palomero

5PUBLICATIONS
66CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 15, 2026
Cabergoline Suppresses Postpartum Breast Cancer by Enhancing Mammary Gland Involution in Brca1-Mutant Mice and Is Associated with Reduced Risk in Younger Women.

|Nov 27, 2025
YM155 Inhibition of Survivin Enhances Carboplatin Efficacy in Metastatic Castration-Resistant Prostate Cancer.

Vicenç Ruiz de Porras, Martin K Bakht, Maria Fernandez-Saorín

|Nov 21, 2023
Topoisomerase 1 Inhibition in MYC-Driven Cancer Promotes Aberrant R-Loop Accumulation to Induce Synthetic Lethality.

Peter Lin, Corey Lourenco, Jennifer Cruickshank

|Feb 11, 2021
Loss of TGFβ signaling increases alternative end-joining DNA repair that sensitizes to genotoxic therapies across cancer types.

Qi Liu, Luis Palomero, Jade Moore

|Dec 02, 2020
FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma.

Adrià Bernat-Peguera, Juan Navarro-Ventura, Laura Lorenzo-Sanz

Pageof 1

Frequent Collaborators

3 joint publications

Miquel Angel Pujana

2 joint publications

Roderic Espín

2 joint publications

Jian-Hua Mao

1 joint publications

Juan Navarro-Ventura